FDA requires a fairly high bar in terms of clinical trail evidence - it is definitely not just a formality.
There have been other IF companies who had to abandon their applications at this stage. Munchkin Grassfed Formula from NZ comes to mind.
I'm not expecting this would happen, but they're not going to be waved through just because they already had temporary access.
FDA requires a fairly high bar in terms of clinical trail...
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $129.3M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 14.0¢ | $88.60K | 628.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 2341672 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 355879 | 10 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
14.3¢ |
Change
0.005 ( 0.07 %) |
||||
| Open | High | Low | Volume | ||
| 14.3¢ | 14.3¢ | 14.0¢ | 313851 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| BUB (ASX) Chart |